These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23792409)

  • 61. Autoimmune diabetes in adults: lessons from the UKPDS.
    Desai M; Clark A
    Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.
    Lindholm E; Hallengren B; Agardh CD
    Diabetes Metab Res Rev; 2004; 20(2):158-64. PubMed ID: 15037992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X; Yang L; Zhou Z; Huang G; Yan X
    Chin Med J (Engl); 2003 Nov; 116(11):1728-32. PubMed ID: 14642146
    [TBL] [Abstract][Full Text] [Related]  

  • 65. GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
    Zampetti S; Capizzi M; Spoletini M; Campagna G; Leto G; Cipolloni L; Tiberti C; Bosi E; Falorni A; Buzzetti R;
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3759-65. PubMed ID: 22865904
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Chronic complications in adult patients with newly diagnosed diabetes mellitus in relation to the presence of humoral autoimmune markers against pancreatic islet cells].
    Szepietowska B; Szelachowska M; Górska M; Jakubczyk D; Kinalska I
    Pol Arch Med Wewn; 2004 May; 111(5):563-9. PubMed ID: 15508807
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Islet autoantibody positivity in overweight and obese adults with type 2 diabetes.
    Pilla SJ; Balasubramanyam A; Knowler WC; Lazo M; Nathan DM; Pi-Sunyer X; Clark JM; Maruthur NM;
    Autoimmunity; 2018 Dec; 51(8):408-416. PubMed ID: 30661481
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Islet autoantibodies in Latvian subjects with non-insulin-dependent diabetes mellitus: slow-onset type 1 diabetes or polyendocrine autoimmunity?
    Shtauvere-Brameus A; Falorni A; Rumba I; Sanjeevi CB
    Ann N Y Acad Sci; 2002 Apr; 958():259-62. PubMed ID: 12021119
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar.
    Alyafei F; Soliman A; Alkhalaf F; Sabt A; De Sanctis V; Elsayed N; Waseef R
    Acta Biomed; 2018 May; 89(S5):32-39. PubMed ID: 30049930
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
    Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
    Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Latent autoimmune diabetes in youth shows greater autoimmunity than latent autoimmune diabetes in adults: Evidence from a nationwide, multicenter, cross-sectional study.
    Cheng J; Tang X; Yan X; Huang G; Luo S; Zhou Z; Li X
    Pediatr Diabetes; 2022 Aug; 23(5):578-587. PubMed ID: 35451144
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low prevalence of autoimmune diabetes markers in a mixed ethnic population of Singaporean diabetics.
    Todd AL; Ng WY; Lui KF; Thai AC
    Intern Med J; 2004; 34(1-2):24-30. PubMed ID: 14748910
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
    Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
    Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pancreatic autoantibodies in Tunisian children with newly diagnosed type 1 diabetes.
    Fakhfakh R; Haddouk S; Hadj Hamida YB; Kamoun T; Ayed MB; Hachicha M; Masmoudi H
    Pathol Biol (Paris); 2008 May; 56(3):130-2. PubMed ID: 18178035
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.
    Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
    Diabetes Metab Res Rev; 2000; 16(6):442-47. PubMed ID: 11114103
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation.
    Eason RJ; Thomas NJ; Hill AV; Knight BA; Carr A; Hattersley AT; McDonald TJ; Shields BM; Jones AG;
    Diabetes Care; 2022 Dec; 45(12):2844-2851. PubMed ID: 36205650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
    Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
    Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
    Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
    Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A].
    Martinka E; Ocenásová A; Straková J; Mokán M
    Vnitr Lek; 1999 Feb; 45(2):97-102. PubMed ID: 15641228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.